NeuroLucent's IP & Technology

• 9 compounds already cleared as effective in AD models, with many more validated core compounds in library
  • ​​Screening in human neurons derived from patients–improves predictive value and chances of success
• One of the few 2-photon laser imaging systems worldwide that can simultaneously measure both intracellular processes and synaptic function
• Extensive Patent Protection

Extensive Patent Protection:

• Patent US20140275112: Compounds for Stabilizing Ryanodine Receptors from Aberrant Levels of Calcium Release: http://www.google.com/patents/US20140275112
• Published in: USA, Canada, China, European Patent Convention, Pending in Japan
• A ‘Continuation-in-part’ to protect additional structures, and ‘Composition of matter’ patents under review
• Exclusive Licensing of all IP from Rosalind Franklin University​